02 May 2003
Effects of 5-AIQ on the multiple organ failure associated to thermal injury in the rat
M. Caneira, B. Sepodes, R. Pinto, H. Mota-Filipe, C. ThiemermannMed Sci Monit 2003; 9(1): 7-0 :: ID: 14992
Abstract
Thermal injury initiates a systemic inflammatory response resulting (among others) in the formation of reactive oxygen species (ROS), which may contribute to DNA injury [1]. One possible way of ROS-induced injury involves the excessive activation of poly-(ADP-ribose) polymerase (PARP). The aim of this study was to investigate the effect of the water-soluble inhibitor of PARP, 5-aminoisoquinoline (5-AIQ) on the circulatory and multiple organ failure in rats with thermal injury.Male Wistar rats (300–350 g) were divided in three groups: Control, burn (B) and burn-treated (BT) with 5-AIQ (3 mg/kg i.p., 1 minute after burn and every 2 h). The rats in groups B and BT received a 60% total body surface area scald burn (70°C during 30 seconds) under general anaesthesia, which was maintained until the end of the experiment. Rats were sacrificed 6 h after the injury and blood samples were collected immediately before sacrifice. Determination of serum biochemical markers of liver injury (AST and ALT) and renal dysfunction (urea and creatinine) was done. Mean arterial blood pressure (MAP) was determined every 30 min. Burned animals shown a significant and progressive decrease in MAP towards the end of 6 h experiment, and this hypotension was unaffected by 5-AIQ. Burn induced a significant increase on the serum levels of AST, ALT, urea and creatinine. This multiple organ injury/dysfunction was significantly attenuated by 5-AIQ. Thus, administration of 5-AIQ immediately after a 60% scald burn attenuated the dysfunction and liver injury, but not the circulatory failure associated with severe burn injury.References: 1.Martin D, Lewington A, Hammerman M, Padanilam B: Inhibition of poly (ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regulatiry Integrative Comp Physiol, 2000; 279: 1834-40
Keywords: thermal injury, Burn, PARP, 5-aminoisoquinoline, Rat
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
15 Mar 2024 : Clinical Research
Evaluation of an Optimized Workflow for the Radiofrequency Catheter Ablation of Paroxysmal Atrial FibrillationMed Sci Monit In Press; DOI: 10.12659/MSM.943526
09 May 2024 : Review article
A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer’s DiseaseMed Sci Monit In Press; DOI: 10.12659/MSM.945091
09 Apr 2024 : Clinical Research
Correlation between Thalamocortical Tract and Default Mode Network with Consciousness Levels in Hypoxic-Isc...Med Sci Monit In Press; DOI: 10.12659/MSM.943802
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952